Annual Current Liabilities
$5.56 M
+$1.11 M+25.03%
December 1, 2023
Summary
- As of February 7, 2025, REVB annual total current liabilities is $5.56 million, with the most recent change of +$1.11 million (+25.03%) on December 1, 2023.
- During the last 3 years, REVB annual current liabilities has risen by +$4.36 million (+360.37%).
- REVB annual current liabilities is now at all-time high.
Performance
REVB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.07 M
-$7.06 M-63.46%
September 1, 2024
Summary
- As of February 7, 2025, REVB quarterly total current liabilities is $4.07 million, with the most recent change of -$7.06 million (-63.46%) on September 1, 2024.
- Over the past year, REVB quarterly current liabilities has dropped by -$7.06 million (-63.46%).
- REVB quarterly current liabilities is now -63.46% below its all-time high of $11.13 million, reached on June 1, 2024.
Performance
REVB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
REVB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.0% | -63.5% |
| 3 y3 years | +360.4% | -63.5% |
| 5 y5 years | - | -63.5% |
REVB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +159.8% | -63.5% | +89.9% |
| 5 y | 5-year | at high | +360.4% | -63.5% | +89.9% |
| alltime | all time | at high | +360.4% | -63.5% | +89.9% |
Revelation Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.07 M(-63.5%) |
| Jun 2024 | - | $11.13 M(+112.9%) |
| Mar 2024 | - | $5.23 M(-6.0%) |
| Dec 2023 | $5.56 M(+25.0%) | $5.56 M(+3.1%) |
| Sep 2023 | - | $5.40 M(+16.8%) |
| Jun 2023 | - | $4.62 M(-42.9%) |
| Mar 2023 | - | $8.10 M(+82.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $4.45 M(+107.8%) | $4.45 M(+1.8%) |
| Sep 2022 | - | $4.37 M(-27.1%) |
| Jun 2022 | - | $6.00 M(-25.8%) |
| Mar 2022 | - | $8.08 M(+277.2%) |
| Dec 2021 | $2.14 M(+77.2%) | $2.14 M(-3.3%) |
| Sep 2021 | - | $2.21 M |
| Dec 2020 | $1.21 M | - |
FAQ
- What is Revelation Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Revelation Biosciences?
- What is Revelation Biosciences annual current liabilities year-on-year change?
- What is Revelation Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Revelation Biosciences?
- What is Revelation Biosciences quarterly current liabilities year-on-year change?
What is Revelation Biosciences annual total current liabilities?
The current annual current liabilities of REVB is $5.56 M
What is the all time high annual current liabilities for Revelation Biosciences?
Revelation Biosciences all-time high annual total current liabilities is $5.56 M
What is Revelation Biosciences annual current liabilities year-on-year change?
Over the past year, REVB annual total current liabilities has changed by +$1.11 M (+25.03%)
What is Revelation Biosciences quarterly total current liabilities?
The current quarterly current liabilities of REVB is $4.07 M
What is the all time high quarterly current liabilities for Revelation Biosciences?
Revelation Biosciences all-time high quarterly total current liabilities is $11.13 M
What is Revelation Biosciences quarterly current liabilities year-on-year change?
Over the past year, REVB quarterly total current liabilities has changed by -$7.06 M (-63.46%)